Protein Engineering Market: Growing Focus on Protein-Based Drug Development By PPosted by Kriti on May 27th, 2021 The research study involves two major activities in estimating the current size of the protein engineering market. Exhaustive research was conducted to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the size of segments and sub-segments. Download a PDF Brochure @https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=898 Major Market Growth Drivers: Revenue Growth Analysis: Based on technology, the Protein Engineering Market is segmented into rational and irrational protein design. The rational protein design segment accounted for the largest share of the market in 2019. The large share of this segment can be attributed to the increasing use and continuous upgrades of bioinformatics platforms and software for protein analysis. Biopharmaceutical companies were the largest end users of protein engineering products and services in 2019 Based on end user, the Protein Engineering Market is segmented into biopharmaceutical companies, contract research organizations, and academic research institutes. The biopharmaceutical companies segment accounted for the largest share of the market in 2019. This is because protein engineering products are widely used for drug discovery and development by biopharmaceutical companies, as they help in designing models to develop a broad range of protein-based drugs. North America accounted for the largest share of the global protein antibody engineering market in 2019 The global Protein Antibody Engineering Market is segmented into four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World. In 2019, North America accounted for the largest share of the global market, closely followed by Europe. Factors such as the presence of well-established CROs, rising R&D expenditure, and the availability of the latest techniques and instruments for drug discovery research are responsible for the large share of the North American market To speak to our analyst for a discussion on the above findings, click Speak to Analyst Key Market Players: Like it? Share it!More by this author |